A new multi-million dollar study at Johns Hopkins University aims to analyze how patients nationwide respond to medical cannabis treatments. Johns Hopkins University, which championed one of the largest and most widely referenced studies on medical applications of psilocybin mushrooms, announced the launch of a medical cannabis study in... Read more
Hemp growers and retailers in Tennessee say that newly proposed regulations threaten the viability of businesses in the industry and vow to challenge the rules before they go into effect, according to media reports. In April, the Tennessee General Assembly passed legislation to regulate and tax hemp products grown,... Read more
The Drug Enforcement Administration (DEA) is now calling for the production of even more THC, psilocybin and DMT for research purposes than it initially proposed for 2024—raising its quotas for those drugs while maintaining already high production goals for marijuana and other psychedelics. In a notice set to be... Read more
South Dakota officials have cleared the way for paid circulators to start collecting signatures for a 2024 marijuana legalization ballot initiative as the activist-led campaign continues to evaluate next steps. Late last month, the secretary of state’s office approved a circulator handout submitted by South Dakotans for Better Marijuana... Read more
Nevada psychedelics activists say they’ve had a “productive meeting” with the Republican governor’s office about the need to expeditiously form a task force under a law enacted earlier this year in order to inform future reform—including the possible legalization of plant-based medicines. About six months after Gov. Joe Lombardo... Read more
A new law went into effect in Nevada on January 1 making several changes to the state’s cannabis laws, including a provision that doubles the state’s limit on weed possession. The measure, Senate Bill 277, was passed by Nevada lawmakers this spring before being signed into law by Republican... Read more
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, 2023 was another tough... Read more
As we described in a previous article, the Global Cannabis Stock Index extended the November bounce after the huge October loss, rallying 8.1% in December. That index was down 20.1% in 2023, which followed a record decline of 70.4% for 2022. In this article, we summarize the performance of the other managed indices that... Read more
